---
input_text: '[Movement disorders: An update]. Movement disorders (tremor, chorea,
  dystonia, tics, and myoclonus) are related to basal ganglia and/or interconnected
  brain areas dysfunction. Clinical examination is a key point in order to characterize
  the abnormal movement and identify associated signs that can guide etiological approach.
  Iatrogenic diseases will be systematically ruled out before conducting additional
  investigations (brain MRI, electrophysiological studies). Wilson disease, but also
  other treatable metabolic and/or genetic diseases, and auto-immune diseases will
  be systematically considered. Therapeutic management is symptomatic and based on
  specific oral drugs appropriate to each movement disorders. In some cases, radiosurgery
  and deep brain stimulation should be helpful, especially for tremor and generalized
  dystonia.'
raw_completion_output: |-
  primary_disease: Movement disorders
  medical_actions: Clinical examination; Iatrogenic diseases ruling out; Brain MRI; Electrophysiological studies; Symptomatic management with specific oral drugs; Radiosurgery; Deep brain stimulation
  symptoms: Tremor; Chorea; Dystonia; Tics; Myoclonus
  chemicals: 
  action_annotation_relationships: Clinical examination TREATS Tremor IN Movement disorders; Clinical examination TREATS Chorea IN Movement disorders; Clinical examination TREATS Dystonia IN Movement disorders; Clinical examination TREATS Tics IN Movement disorders; Clinical examination TREATS Myoclonus IN Movement disorders; Symptomatic management with specific oral drugs TREATS Tremor IN Movement disorders; Symptomatic management with specific oral drugs TREATS Chorea IN Movement disorders; Symptomatic management with specific oral drugs TREATS Dystonia IN Movement disorders; Symptomatic management with specific oral drugs TREATS Tics IN Movement disorders; Symptomatic management with specific oral drugs TREATS Myoclonus IN Movement disorders; Radiosurgery TREATS Tremor IN Movement disorders; Radiosurgery TREATS Dystonia IN Movement disorders; Deep brain stimulation TREATS Tremor IN Movement disorders; Deep brain stimulation TREATS Dystonia IN Movement disorders
prompt: |+
  Split the following piece of text into fields in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Deep brain stimulation TREATS Dystonia IN Movement disorders

  ===

extracted_object:
  primary_disease: MONDO:0005395
  medical_actions:
    - MAXO:0000526
    - Iatrogenic diseases ruling out
    - MAXO:0000427
    - Electrophysiological studies
    - Symptomatic management with specific oral drugs
    - Radiosurgery
    - MAXO:0000943
  symptoms:
    - HP:0001337
    - HP:0002072
    - HP:0001332
    - HP:0100033
    - HP:0001336
  action_annotation_relationships:
    - subject: MAXO:0000526
      predicate: TREATS
      object: HP:0001337
      qualifier: MONDO:0005395
    - subject: MAXO:0000526
      predicate: TREATS
      object: HP:0002072
      qualifier: MONDO:0005395
    - subject: MAXO:0000526
      predicate: TREATS
      object: HP:0001332
      qualifier: MONDO:0005395
    - subject: MAXO:0000526
      predicate: TREATS
      object: HP:0100033
      qualifier: MONDO:0005395
    - subject: MAXO:0000526
      predicate: TREATS
      object: HP:0001336
      qualifier: MONDO:0005395
    - subject: <Symptomatic management>
      predicate: <TREATS>
      object: <Tremor>
      qualifier: <Movement disorders>
      subject_extension: <specific oral drugs>
    - subject: Symptomatic management
      predicate: TREATS
      object: HP:0002072
      qualifier: MONDO:0005395
      subject_extension: specific oral drugs
    - subject: Symptomatic management
      predicate: TREATS
      object: HP:0001332
      qualifier: MONDO:0005395
      subject_qualifier: with specific oral drugs
      subject_extension: specific oral drugs
    - subject: Symptomatic management
      predicate: TREATS
      object: HP:0100033
      qualifier: MONDO:0005395
      subject_extension: specific oral drugs
    - subject: Symptomatic management
      predicate: TREATS
      object: HP:0001336
      qualifier: MONDO:0005395
      subject_qualifier: with specific oral drugs
      subject_extension: specific oral drugs
    - subject: Radiosurgery
      predicate: TREATS
      object: HP:0001337
      qualifier: MONDO:0005395
    - subject: Radiosurgery
      predicate: TREATS
      object: HP:0001332
      qualifier: MONDO:0005395
    - subject: MAXO:0000943
      predicate: TREATS
      object: HP:0001337
      qualifier: MONDO:0005395
    - subject: MAXO:0000943
      predicate: TREATS
      object: HP:0001332
      qualifier: MONDO:0005395
named_entities:
  - id: MONDO:0010200
    label: Wilson's disease
  - id: MAXO:0001175
    label: liver transplantation
  - id: HP:0001695
    label: cardiac arrest
  - id: HP:0001685
    label: myocardial fibrosis
  - id: HP:0001663
    label: ventricular fibrillation
  - id: CHEBI:30703
    label: tetrathiomolybdate (TTM)
  - id: CHEBI:35176
    label: Zinc sulphate
  - id: CHEBI:35475
    label: NSAIDs
  - id: MAXO:0001001
    label: Gene therapy
  - id: HP:0006554
    label: acute liver failure
  - id: HP:0003256
    label: coagulopathy
  - id: HP:0002480
    label: hepatic encephalopathy
  - id: HP:0001337
    label: Tremor
  - id: HP:0001332
    label: Dystonia
  - id: CHEBI:28694
    label: Copper
  - id: HP:0001395
    label: Liver fibrosis
  - id: HP:0001394
    label: Cirrhosis
  - id: CHEBI:39501
    label: trientine
  - id: CHEBI:27363
    label: zinc
  - id: HP:0001410
    label: hepatic dysfunction
  - id: CHEBI:7959
    label: D-penicillamine
  - id: MAXO:0000376
    label: Liver biopsy
  - id: HP:0001404
    label: Hepatocellular necrosis
  - id: CHEBI:61049
    label: Tacrolimus
  - id: CHEBI:50868
    label: Penicillamine
  - id: HP:0001744
    label: splenomegaly
  - id: HP:0001541
    label: ascites
  - id: HP:0001260
    label: Dysarthria
  - id: HP:0001347
    label: Hyperreflexia
  - id: HP:0031843
    label: Bradyphrenia
  - id: HP:0002362
    label: Shuffling gait
  - id: HP:0002300
    label: Mutism
  - id: HP:0001621
    label: Hypophonia
  - id: CHEBI:37153
    label: Calcineurin inhibitors
  - id: CHEBI:8356
    label: Pramipexole
  - id: CHEBI:2618
    label: Amantadine
  - id: HP:0001399
    label: liver failure
  - id: HP:0000952
    label: jaundice
  - id: HP:0001919
    label: acute kidney injury
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: MONDO:0013792
    label: Intracerebral Hemorrhage
  - id: HP:0001342
    label: Intracerebral Hemorrhage
  - id: MAXO:0000533
    label: Molecular genetic testing
  - id: HP:0001873
    label: thrombocytopenia
  - id: HP:0002344
    label: worsening neurological symptoms
  - id: HP:0001272
    label: Cerebellar Atrophy
  - id: HP:0012896
    label: abnormal motor evoked potentials (MEPs)
  - id: HP:0001392
    label: liver disease
  - id: HP:0001396
    label: cholestasis
  - id: HP:0001403
    label: macrovesicular steatosis
  - id: CHEBI:8830
    label: rhodanine
  - id: CHEBI:90299
    label: orcein
  - id: MONDO:0018874
    label: Acute Myeloid Leukemia (t-AML or AML-MRC)
  - id: CHEBI:41977
    label: Daunorubicin
  - id: CHEBI:28680
    label: Cytarabine
  - id: CHEBI:37404
    label: Elemental copper
  - id: CHEBI:16856
    label: Plasma glutathione (GSH)
  - id: CHEBI:53498
    label: Total antioxidant capacity (TAC)
  - id: CHEBI:566274
    label: Malondialdehyde (MDA)
  - id: CHEBI:33697
    label: RNAs
  - id: HP:0000989
    label: itchy skin
  - id: CHEBI:63623
    label: Dimercaptosuccinic acid
  - id: CHEBI:145810
    label: insulin
  - id: HP:0001250
    label: Epileptic seizures
  - id: HP:0001298
    label: Encephalopathy
  - id: HP:0002315
    label: Headache
  - id: CHEBI:6437
    label: Levetiracetam
  - id: HP:0002878
    label: Acute respiratory failure
  - id: CHEBI:166831
    label: copper chelating agents
  - id: MONDO:0004789
    label: Cholangitis
  - id: MAXO:0010026
    label: zinc supplementation
  - id: CHEBI:16796
    label: Melatonin
  - id: MAXO:0009095
    label: Zinc (Zn) therapy
  - id: MAXO:0001298
    label: therapy
  - id: CHEBI:38161
    label: Chelator
  - id: MONDO:0019542
    label: Acute Liver Failure (ALF)
  - id: HP:0002204
    label: Pulmonary embolism
  - id: HP:0100806
    label: Sepsis
  - id: HP:0001944
    label: dehydration
  - id: CHEBI:18248
    label: iron
  - id: CHEBI:18291
    label: manganese
  - id: CHEBI:22984
    label: calcium
  - id: HP:0001081
    label: Cholelithiasis
  - id: HP:0002716
    label: Lymphadenopathy
  - id: MONDO:0100193
    label: End-stage liver diseases
  - id: HP:0002040
    label: Esophageal varices
  - id: HP:0100626
    label: End-stage liver diseases
  - id: MONDO:0017014
    label: children
  - id: MAXO:0009016
    label: Botulinum toxin type A (BoNT-A) injection
  - id: CHEBI:3160
    label: Botulinum toxin type A (BoNT-A)
  - id: HP:0003088
    label: Premature osteoarthritis
  - id: HP:0002885
    label: Mallory-Denk body (MDB) formation
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:16990
    label: Bilirubin
  - id: MONDO:0100192
    label: Liver failure
  - id: HP:0001409
    label: Portal hypertension
  - id: HP:0001402
    label: Hepatocellular carcinoma
  - id: CHEBI:30663
    label: Serum ceruloplasmin (CP)
  - id: HP:0001513
    label: obesity
  - id: CHEBI:16610
    label: spermidine
  - id: CHEBI:27881
    label: resveratrol
  - id: CHEBI:15351
    label: AcCoA
  - id: HP:0001300
    label: Parkinsonism
  - id: CHEBI:62984
    label: zinc acetate
  - id: MAXO:0000165
    label: treatment with diuretics
  - id: CHEBI:35498
    label: diuretics
  - id: CHEBI:33281
    label: antibiotics
  - id: CHEBI:50503
    label: laxatives
  - id: CHEBI:76649
    label: Aspartate aminotransferase (AST)
  - id: CHEBI:37708
    label: Alanine aminotransferase (ALT)
  - id: HP:0011967
    label: Copper deficiency
  - id: CHEBI:38127
    label: Thiocarbamate
  - id: CHEBI:25548
    label: Nitrilotriacetate
  - id: CHEBI:16494
    label: Lipoic acid
  - id: MONDO:0010651
    label: Menkes disease
  - id: MAXO:0000127
    label: genetic testing
  - id: CHEBI:64357
    label: rituximab
  - id: CHEBI:18132
    label: CHOP
  - id: HP:0002665
    label: lymphoma
  - id: MONDO:0005395
    label: Movement disorders
  - id: MAXO:0000526
    label: Clinical examination
  - id: MAXO:0000427
    label: Brain MRI
  - id: MAXO:0000943
    label: Deep brain stimulation
  - id: HP:0002072
    label: Chorea
  - id: HP:0100033
    label: Tics
  - id: HP:0001336
    label: Myoclonus
